TV presenter Alexander Myasnikov told what drugs can serve as prevention of coronavirus groups with risk factors to receive vaccines.
According to him, a powerful weapon is a monoclonal antibody. They represent a new class of drugs already used in clinical practice.
Antibodies is the most important part of our acquired immunity. In response to infection or something else alien to us introduction our cells begin to produce a lot of specific proteins-antibodies. But as calves from different cows, though of the same breed differ from each other, and all these antibodies are slightly different, — said Myasnikov in his Telegram channel.
He added that preparations for the prevention COVID-19 end in “MAB” (“monoclinic anti body”) — Tocilizumab, Remesiana, Umisisweb. They are effective in high-risk groups to prevent severe disease, although expensive.
Earlier NEWS.ru reported that clinical trials of the Russian vaccine against COVID-19, developed with the participation of the defense Ministry, will hang. The latest group of 20 volunteers July 20, will leave the Main military clinical hospital named after Burdenko. Scientists will analyze the test results and make final reports. However, it is known that as a result of vaccination in volunteers revealed antibodies to COVID-19. The components of the vaccine safe and well tolerated.
